Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancer Letters|April 23, 2016
Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activityKim De Veirman, Jinheng Wang, Song Xu, et al.
Cancers|October 14, 2022
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative StudyRobbe Heestermans, Wouter De Brouwer, Ken Maes, et al.
Blood Cancer Journal|November 10, 2018
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblastsSylvia Faict, Joséphine Muller, Kim De Veirman, et al.
Blood|August 4, 2010
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2Ken Maes, Elizabeta Nemeth, G David Roodman, et al.
Journal of Medical Case Reports|May 13, 2023
Peripheral precocious puberty in Li-Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumorsSofie Ryckx, Jean De Schepper, Philippe Giron, et al.
Frontiers in Cell and Developmental Biology|June 27, 2022
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment ApproachPhilip Vlummens, Stefaan Verhulst, Kim De Veirman, et al.
Oncotarget|June 2, 2018
Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cellsNathan De Beule, Eline Menu, Mathieu J M Bertrand, et al.
Oncotarget|September 9, 2017
Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cellsNathan De Beule, Eline Menu, Mathieu J M Bertrand, et al.
Molecular Pharmaceutics|August 14, 2020
Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian CancerYana Dekempeneer, Vicky Caveliers, Maarten Ooms, et al.
International Journal of Cancer|June 8, 2026
Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant PairsFreya Vaeyens, Jan-Patrick Hetzel, Khaldoon Abdullah, et al.
Pageof 5